尔康制药
(300267)
| 流通市值：53.77亿 | | | 总市值：77.97亿 |
| 流通股本：14.22亿 | | | 总股本：20.63亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 492,515,859.62 | 686,061,848.21 | 698,537,949.74 | 668,368,156.84 |
| 交易性金融资产 | 60,000,000 | 20,000,000 | 120,000,000 | 100,000,000 |
| 应收票据及应收账款 | 186,741,635.39 | 168,086,915.87 | 151,266,539.49 | 131,476,574.59 |
| 其中：应收票据 | 24,038,250.13 | 27,231,063.65 | 48,084,670.21 | 40,464,805.57 |
| 应收账款 | 162,703,385.26 | 140,855,852.22 | 103,181,869.28 | 91,011,769.02 |
| 应收款项融资 | 43,202,655.2 | 50,276,469.3 | 47,037,042.74 | 26,909,443.34 |
| 预付款项 | 26,581,613.81 | 6,918,682.48 | 22,581,009.48 | 13,128,590.3 |
| 其他应收款合计 | 3,795,220.47 | 5,577,491.91 | 4,463,359.97 | 25,487,884.74 |
| 存货 | 625,389,003.86 | 670,915,258.88 | 600,778,587.41 | 648,344,562.54 |
| 其他流动资产 | 177,773,363.42 | 68,878,749.9 | 72,417,167.53 | 65,334,745.09 |
| 流动资产合计 | 1,615,999,351.77 | 1,676,715,416.55 | 1,717,081,656.36 | 1,679,049,957.44 |
| 非流动资产: | | | | |
| 长期股权投资 | 71,738,178.56 | 71,733,391.18 | 71,740,298.04 | 119,527,524.25 |
| 其他权益工具投资 | 50,000,000 | 50,000,000 | 50,000,000 | 50,000,000 |
| 投资性房地产 | 76,479,834.15 | 77,281,203.94 | 78,082,573.77 | 78,883,943.56 |
| 固定资产 | 2,329,876,053.71 | 2,358,642,775.69 | 2,384,972,862.95 | 2,518,734,356.88 |
| 在建工程 | 193,497,744.49 | 180,278,281.81 | 174,575,234.39 | 236,790,125.51 |
| 使用权资产 | 166,245,543.3 | 152,001,178.79 | 156,810,231.01 | 136,505,911.58 |
| 无形资产 | 353,852,829.2 | 359,177,359.72 | 363,556,194.17 | 361,014,016.27 |
| 商誉 | 2,003,166.56 | 2,003,166.56 | 2,003,166.56 | 2,003,166.56 |
| 长期待摊费用 | 10,982,868.74 | 10,347,062.14 | 10,664,002.9 | 10,900,394.24 |
| 递延所得税资产 | 148,619,262.29 | 148,937,537.3 | 150,546,083.18 | 151,790,359.25 |
| 其他非流动资产 | 30,596,047.96 | 37,212,303.23 | 39,702,187.86 | 48,893,224.32 |
| 非流动资产合计 | 3,433,891,528.96 | 3,447,614,260.36 | 3,482,652,834.83 | 3,715,043,022.42 |
| 资产总计 | 5,049,890,880.73 | 5,124,329,676.91 | 5,199,734,491.19 | 5,394,092,979.86 |
| 流动负债: | | | | |
| 短期借款 | 310,082,500 | 401,261,527.78 | 488,198,472.23 | 399,393,472.23 |
| 交易性金融负债 | - | - | - | 822,000 |
| 衍生金融负债 | 3,943,429.92 | - | - | - |
| 应付票据及应付账款 | 130,879,711.62 | 121,501,523.94 | 114,656,240.33 | 122,547,840.63 |
| 应付账款 | 130,879,711.62 | 121,501,523.94 | 114,656,240.33 | 122,547,840.63 |
| 合同负债 | 34,459,211.16 | 44,888,164.22 | 29,823,202.4 | 41,502,079.52 |
| 应付职工薪酬 | 8,781,917.63 | 9,288,902.95 | 20,222,658.14 | 9,363,539 |
| 应交税费 | 3,006,654.27 | 2,379,211.6 | 6,675,631.41 | 7,246,251.91 |
| 其他应付款合计 | 26,334,744.18 | 26,497,619.26 | 28,565,572.26 | 26,546,086.95 |
| 一年内到期的非流动负债 | 6,297,340.06 | 3,693,788.51 | 3,693,966.4 | 920,021.89 |
| 其他流动负债 | 10,082,426.3 | 9,309,400.67 | 13,506,321.09 | 18,600,848.6 |
| 流动负债合计 | 533,867,935.14 | 618,820,138.93 | 705,342,064.26 | 626,942,140.73 |
| 非流动负债: | | | | |
| 租赁负债 | 28,693,744.25 | 17,087,226.53 | 17,375,180.58 | 5,962,052.91 |
| 预计负债 | 12,993,511.88 | 12,993,511.88 | 12,993,511.88 | - |
| 递延收益 | 12,463,304.34 | 13,690,331.97 | 14,929,804.05 | 16,169,276.13 |
| 递延所得税负债 | 46,424,423.65 | 46,979,360.13 | 46,900,119.93 | 46,670,219.89 |
| 非流动负债合计 | 100,574,984.12 | 90,750,430.51 | 92,198,616.44 | 68,801,548.93 |
| 负债合计 | 634,442,919.26 | 709,570,569.44 | 797,540,680.7 | 695,743,689.66 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,062,604,870 | 2,062,604,870 | 2,062,604,870 | 2,062,604,870 |
| 资本公积 | 1,019,459,930.44 | 1,019,459,930.44 | 1,019,459,930.44 | 1,019,459,930.44 |
| 其他综合收益 | 44,763,936.08 | 49,104,126.31 | 60,572,012.39 | -8,886,059.68 |
| 专项储备 | 986,452.65 | 871,530.76 | 697,655.76 | 664,399.18 |
| 盈余公积 | 138,000,248.18 | 138,000,248.18 | 138,000,248.18 | 129,884,442.27 |
| 未分配利润 | 1,203,725,458.17 | 1,194,203,400.81 | 1,166,090,815.59 | 1,522,110,741.09 |
| 归属于母公司股东权益合计 | 4,469,540,895.52 | 4,464,244,106.5 | 4,447,425,532.36 | 4,725,838,323.3 |
| 少数股东权益 | -54,092,934.05 | -49,484,999.03 | -45,231,721.87 | -27,489,033.1 |
| 股东权益合计 | 4,415,447,961.47 | 4,414,759,107.47 | 4,402,193,810.49 | 4,698,349,290.2 |
| 负债和股东权益合计 | 5,049,890,880.73 | 5,124,329,676.91 | 5,199,734,491.19 | 5,394,092,979.86 |
| 公告日期 | 2025-08-28 | 2025-04-23 | 2025-04-23 | 2024-10-25 |
| 审计意见(境内) | | | 标准无保留意见 | |